Vaccine News and Research

Latest Vaccine News and Research

UCLA creates new program that helps adoptive parents, children navigate through international adoption process

With thousands of internationally adopted children arriving in the United States each year, there is a growing demand for a specialized health-care support system that helps adoptive parents and children navigate through the international adoption process.

19 Mar 2014

Uptake for HPV jab below 80% required to make significant impact on cervical cancer

Young women who are most at risk of developing cervical cancer are the least likely to be offered the protective HPV jab and to complete the full course when they are, reveals research published online in the journal Sexually Transmitted Infections.

18 Mar 2014

UC baby health innovation wins Gates award

An innovative, colourful and accessible design to improve child health records worldwide has earned a University of Canberra graphic design lecturer a prestigious international award.

17 Mar 2014

MD Anderson collaborates with MedImmune to develop therapies that unleash patients' immune systems to attack cancers

The University of Texas MD Anderson Cancer Center and MedImmune, the global biologics research and development arm of AstraZeneca, will collaborate through MD Anderson's Moon Shots Program to develop therapies that unleash patients' immune systems to attack their cancers.

14 Mar 2014

Australians it's time to consider a flu vaccination

Although it is still early in the season, NPS MedicineWise is joining other health experts in recommending that people at risk of complications of the flu (influenza) get vaccinated against the illness.

13 Mar 2014

Two synergistic therapies allow solid tumors to act as their own cancer-fighting vaccine

Researchers in the Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute eradicated solid tumors in laboratory mice using a novel combination of two targeted agents. These two synergistic therapies stimulate an immune response, ultimately allowing solid tumors to act as their own cancer-fighting vaccine.

13 Mar 2014

Women who experience gestational diabetes may face increased risk of heart disease later in life

Women who experience gestational diabetes may face an increased risk of early heart disease later in life, even if they do not develop type 2 diabetes or metabolic syndrome subsequent to their pregnancy, according to a Kaiser Permanente study published today in the Journal of the American Heart Association.

13 Mar 2014

Teen researcher wins top award from Intel Foundation for research on potential drugs to treat influenza

From new cancer treatments to an exploration of how technology affects the adolescent brain, the innovative research of America's future scientists, engineers and inventors took center stage in the nation's capital today.

12 Mar 2014

One person's unique ability provides key insights into immune response to fight HIV

One person's unique ability to fight HIV has provided key insights into an immune response that researchers now hope to trigger with a vaccine, according to findings reported by a team that includes Duke Medicine scientists.

11 Mar 2014

UTSA College of Sciences faculty members honored at 2014 Annual Meeting of AAAS

UTSA College of Sciences faculty members Andrew Tsin, Garry Cole and Donald Kurtz were honored recently at the 2014 Annual Meeting of the American Association for the Advancement of Science (AAAS) in Chicago.

11 Mar 2014

Thirteen graduate students to receive 2014 Harold M. Weintraub Graduate Student Award

Thirteen graduate students from institutes throughout North America have been chosen to receive the 2014 Harold M. Weintraub Graduate Student Award sponsored by the Basic Sciences Division of Fred Hutchinson Cancer Research Center.

11 Mar 2014

Controlled TB vaccine trial designed to study prevention of Mtb infection by vaccination

Aeras today announced the initiation of the first randomized, controlled tuberculosis (TB) vaccine trial designed to study prevention of Mycobacterium tuberculosis (Mtb) infection by vaccination.

11 Mar 2014

Scientists discover new protein that drive metastasis of cancer cells

An international team of researchers led by scientists at The Wistar Institute have discovered and defined LIMD2, a protein that can drive metastasis, the process where tumors spread throughout the body.

11 Mar 2014

Erlotinib has promising potential to improve treatment for cervical cancer

A new clinical study has found that erlotinib, a targeted antitumor agent, has promising potential to improve treatment for cervical cancer. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the results indicate that larger trials are warranted to determine whether the drug should become part of standard therapy for women with the disease.

10 Mar 2014

Ludwig, Agenus to advance three monoclonal antibody checkpoint modulators into preclinical development

Ludwig Cancer Research and Agenus Inc. today announced the selection of three monoclonal antibody checkpoint modulators (CPMs) that Agenus is advancing into preclinical development.

7 Mar 2014

Researcher wins grant from NCI to continue developing new therapy for bladder cancer

A biomedical engineering researcher at the University of Arkansas will use a $416,897 grant from the National Cancer Institute to continue developing a new therapy for bladder cancer.

6 Mar 2014

Researchers awarded $26M NIH grant to advance treatments for Ebola and Marburg

The University of Texas Medical Branch at Galveston, Profectus Biosciences, Tekmira Pharmaceuticals and the Vanderbilt University Medical Center have been awarded up to $26 million to advance treatments of the highly lethal hemorrhagic fever viruses Ebola and Marburg.

6 Mar 2014

Costs for medications expected to rise by 3 – 5% in all health care settings in 2014

Costs for medications are expected to rise by three to five percent in all health care settings in 2014, according to a report published online ahead of print, by the American Journal of Health-System Pharmacy (AJHP), the professional journal of the American Society of Health-System Pharmacists (ASHP).

6 Mar 2014

Researchers find 69% rise in pertussis vaccination rate among new mothers

Changing the hospital orders for women who have just delivered a child led to a 69% increase in the new mothers' pertussis vaccination rate, providing protection for themselves and their newborns against the disease, commonly known as whooping cough, according to a study in the March issue of the American Journal of Obstetrics & Gynecology.

6 Mar 2014

Novel cancer immunotherapy approach may provide new weapon against most deadly tumors

A novel approach to cancer immunotherapy - strategies designed to induce the immune system to attack cancer cells - may provide a new and cost-effective weapon against some of the most deadly tumors, including ovarian cancer and mesothelioma.

6 Mar 2014

Vaccine News and Research

Latest Vaccine News and Research

UCLA creates new program that helps adoptive parents, children navigate through international adoption process

Uptake for HPV jab below 80% required to make significant impact on cervical cancer

UC baby health innovation wins Gates award

MD Anderson collaborates with MedImmune to develop therapies that unleash patients' immune systems to attack cancers

Australians it's time to consider a flu vaccination

Two synergistic therapies allow solid tumors to act as their own cancer-fighting vaccine

Women who experience gestational diabetes may face increased risk of heart disease later in life

Teen researcher wins top award from Intel Foundation for research on potential drugs to treat influenza

One person's unique ability provides key insights into immune response to fight HIV

UTSA College of Sciences faculty members honored at 2014 Annual Meeting of AAAS

Thirteen graduate students to receive 2014 Harold M. Weintraub Graduate Student Award

Controlled TB vaccine trial designed to study prevention of Mtb infection by vaccination

Scientists discover new protein that drive metastasis of cancer cells

Erlotinib has promising potential to improve treatment for cervical cancer

Ludwig, Agenus to advance three monoclonal antibody checkpoint modulators into preclinical development

Researcher wins grant from NCI to continue developing new therapy for bladder cancer

Researchers awarded $26M NIH grant to advance treatments for Ebola and Marburg

Costs for medications expected to rise by 3 – 5% in all health care settings in 2014

Researchers find 69% rise in pertussis vaccination rate among new mothers

Novel cancer immunotherapy approach may provide new weapon against most deadly tumors

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in